|5Feb 13, 4:30 PM ET

New Enterprise Associates 16, L.P. 5

5 · Trevi Therapeutics, Inc. · Filed Feb 13, 2026

Insider Transaction Report

Form 5
Period: 2025-12-31
Transactions
  • Exercise of In-Money

    Common Stock

    [F1]
    2025-04-17$1.37/sh+1,851,852$2,537,03712,273,280 total
  • Exercise of In-Money

    3.5-Year Common Stock Warrant

    [F1]
    2025-04-171,851,8520 total
    Exercise: $1.37From: 2021-10-18Exp: 2025-04-18Common Stock (1,851,852 underlying)
Footnotes (1)
  • [F1]The securities are directly held by NEA 16, and indirectly held by NEA Partners 16, L.P. ("NEA Partners"), the sole general partner of NEA 16, NEA 16 GP, LLC ("NEA 16 GP"), the sole general partner of NEA Partners 16, and the individual managers of NEA 16 GP (NEA Partners 16, NEA 16 GP and the individual managers of NEA 16 GP (collectively, the "Managers"), together, the "Indirect Reporting Persons"). The Managers of NEA 16 GP are Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad Makhzoumi, Scott D. Sandell and Paul Walker. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Indirect Reporting Persons have no pecuniary interest.
Signature
/s/ Zachary Bambach, attorney-in-fact|2026-02-13

Documents

1 file
  • 5
    ownership.xmlPrimary

    5